Bausch & Lomb takes posterior uveitis implant to the US
This article was originally published in Clinica
Executive Summary
The US FDA has given Bausch & Lomb (B&L) the all-clear to market its eye implant for treating the sight-threatening inflammatory disease, posterior uveitis.